| | | | | | | | | | | | | | | | | | | | | | |
EDGAR Submission
|
| Header Data: |
| Submission Type: 1-A/A |
| Filer Info: |
| | Live-Test Flag: LIVE |
| | Filer: |
| | | Issuer Credentials: |
| CIK: 1776073 |
| CCC: XXXXXXXX |
| | | Offering File Number: 024-11005 |
| Form Data: |
| Employees Info: |
| | Issuer Name: CBD Life Sciences, Inc. |
| | Jurisdiction Organization: NV |
| | Year Incorporation: 1998 |
| | CIK: 1776073 |
| | Sic Code: 5900 |
| | IRS Num.: 20-5118532 |
| | Full Time Employees: 5 |
| | Part Time Employees: 0 |
| Issuer Info: |
| | Street 1: 11445 E. VIA LINDA, UNIT 2-496 |
| | City: SCOTTSDALE |
| | State or Country: AZ |
| | ZIP Code: 85259 |
| | Phone Number: 480-776-0281 |
| | Connection Name: John E. Lux, Esq. |
| | Industry Group: Other |
| | Cash Equivalents: 26,354.00 |
| | Investment Securities: 0.00 |
| | Accounts Receivable: 148,847.00 |
| | Property Plant Equipment: 0.00 |
| | Total Assets: 1,484,862.00 |
| | Accounts Payable: 116,470.00 |
| | Long Term Debt: 448,110.00 |
| | Total Liabilities: 564,580.00 |
| | Total Stockholder Equity: 920,282.00 |
| | Total Liabilities and Equity: 1,484,862.00 |
| | Total Revenues: 63,729.00 |
| | Cost and Expenses Appl to Revenues: 488,208.00 |
| | Depreciation and Amortization: 0.00 |
| | Net Income: -638,874.00 |
| | Earnings Per Share Basic: -0.02 |
| | Earnings Per Share Diluted: -0.02 |
| Common Equity: |
| | Common Equity Class Name: Common Stock, $0.001 par value |
| | Outstanding Common Equity: 378341280 |
| | Common CUSIP Equity: 68403M-20-0 |
| | Publicly Traded Common Equity: OTC Markets |
| Preferred Equity: |
| | Preferred Equity Class Name: Series A Non-Convertible |
| | Outstanding Preferred Equity: 16081530 |
| | Preferred CUSIP Equity: 000000-00-0 |
| | Publicly Traded Preferred Equity: none |
| Debt Securities: |
| | Debt Securities Class Name: not applicable |
| | Outstanding Debt Securities: 0 |
| | CUSIP Debt Securities: 000000-00-0 |
| | Publicly Traded Debt Securities: none |
| Issuer Eligibility: |
| | Certify If True? Yes |
| Application Rule 262: |
| | Certify If Not Disqualified? Yes |
| Summary Info: |
| | Indicate Tier 1 Tier 2 Offering: Tier1 |
| | Financial Statement Audit Status: Unaudited |
| | Securities Offered Types: Equity (common or preferred stock) |
| | Offer Delayed Continuous Flag? Yes |
| | Offering Year Flag? No |
| | Offering After Qualif Flag? No |
| | Offering Best Efforts Flag? Yes |
| | Solicitation Proposed Offering Flag? No |
| | Resale Securities Affiliates Flag? No |
| | Securities Offered: 400000000 |
| | Outstanding Securities: 378341280 |
| | Price Per Security: 0.0050 |
| | Issuer Aggregate Offering: 2,000,000.00 |
| | Security Holder Aggegate: 0.00 |
| | Qualification Offering Aggregate: 0.00 |
| | Concurrent Offering Aggregate: 0.00 |
| | Total Aggregate Offering: 2,000,000.00 |
| | Legal Service Provider Name: John E. Lux, Esq. |
| | Legal Fees: 25,000.00 |
| | Blue Sky Service Provider Name: Various states |
| | Blue Sky Fees: 2,500.00 |
| | Estimated Net Amount: 1,920,000.00 |
| Juridiction Securities Offered: |
| | Jurisdictions of SEC Offered Same? Yes |
| | Issue Juridication Securities Offering: CO |
| | Issue Juridication Securities Offering: NY |
| | Dealers Juridication Securities Offering: CO |
| | Dealers Juridication Securities Offering: NY |
| Securities Issued: |
| | Securities Issuer Name: CBD Life Sciences, Inc. |
| | Securities Issuer Title: Common Stock, $0.001 par value |
| | Securities Issued Total Amount: 1,458,088 |
| | Securities Principal Holder Amount: 0 |
| | Securities Issued Aggregate Amount: 550,146 |
| Unregistered Securities Act: |
| | Securities Act Excemption: Sections 3(a)(10), 4(a)(1) |
